Oriola Oyj
LSE:0NES
Intrinsic Value
Oriola Corp. engages in the provision of pharmaceutical, and health and well-being products retail and wholesale. [ Read More ]
The intrinsic value of one 0NES stock under the Base Case scenario is 856.7002 EUR. Compared to the current market price of 2.3425 EUR, Oriola Oyj is Undervalued by 100%.
Fundamental Analysis
Balance Sheet Decomposition
Oriola Oyj
| Current Assets | 587.1m |
| Cash & Short-Term Investments | 138.4m |
| Receivables | 273.9m |
| Other Current Assets | 174.8m |
| Non-Current Assets | 347.6m |
| Long-Term Investments | 235.4m |
| PP&E | 45m |
| Intangibles | 51.2m |
| Other Non-Current Assets | 16m |
| Current Liabilities | 739.1m |
| Accounts Payable | 607.5m |
| Other Current Liabilities | 131.6m |
| Non-Current Liabilities | 24.3m |
| Long-Term Debt | 7.1m |
| Other Non-Current Liabilities | 17.2m |
Earnings Waterfall
Oriola Oyj
|
Revenue
|
1.5B
EUR
|
|
Cost of Revenue
|
-1.3B
EUR
|
|
Gross Profit
|
159.7m
EUR
|
|
Operating Expenses
|
-165m
EUR
|
|
Operating Income
|
-5.3m
EUR
|
|
Other Expenses
|
-15.4m
EUR
|
|
Net Income
|
-20.7m
EUR
|
Free Cash Flow Analysis
Oriola Oyj
0NES Profitability Score
Profitability Due Diligence
Oriola Oyj's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
Score
Oriola Oyj's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
0NES Solvency Score
Solvency Due Diligence
Oriola Oyj's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Score
Oriola Oyj's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
0NES Price Targets Summary
Oriola Oyj
According to Wall Street analysts, the average 1-year price target for 0NES is 1.1927 EUR with a low forecast of 1.1478 EUR and a high forecast of 1.2451 EUR.
Shareholder Return
OKDBV Price
Oriola Oyj
| Average Annual Return | -1.86% |
| Standard Deviation of Annual Returns | 7.37% |
| Max Drawdown | -59% |
| Market Capitalization | 166m EUR |
| Shares Outstanding | 181 423 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Oriola Corp. engages in the provision of pharmaceutical, and health and well-being products retail and wholesale. The company is headquartered in Espoo, Etela-Suomen and currently employs 2,645 full-time employees. The company went IPO on 2006-07-03. The firm is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The firm's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The firm is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.
You don't have any saved screeners yet
